Spinal muscular atrophy type 1: Are proactive respiratory interventions associated with longer survival?

Pediatric Critical Care Medicine

Volumn 13, Issue 3, 2012, Pages

  Lemoine, Tara J ^a   Swoboda, Kathryn J ^a   Bratton, Susan L ^a   Holubkov, Richard ^a   Mundorff, Michael ^b   Srivastava, Rajendu ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

noninvasive ventilation; respiratory failure; spinal muscular atrophy; survival analysis

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; CAREGIVER; CHILDHOOD DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; INFANT; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY CARE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SPINAL MUSCULAR ATROPHY; SURVIVAL; TRACHEOSTOMY;

COHORT STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; INFANT; INTENTION TO TREAT ANALYSIS; MALE; PALLIATIVE CARE; RESPIRATORY INSUFFICIENCY; RESPIRATORY THERAPY; RETROSPECTIVE STUDIES; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTAH;

EID: 84861097868     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3182388ad1     Document Type: Article

References (22)

1. Lunn MR, Wang CH: Spinal muscular atrophy. Lancet 2008; 371:2120-2133 (Pubitemid 351842582)
2. Zerres K, Wirth B, Rudnik-Schöneborn S: Spinal muscular atrophy-clinical and genetic correlations. Neuromuscul Disord 1997; 7:202-207 (Pubitemid 27243812)
3. Cobben JM, Lemmink HH, Snoeck I, et al: Survival in SMA type I: A prospective analysis of 34 consecutive cases. Neuromuscul Disord 2008; 18:541-544
4. Rudnik-Schöneborn S, Berg C, Zerres K, et al: Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: Implications for clinical trials and genetic counselling. Clin Genet 2009; 76:168-178
5. Bach JR, Niranjan V, Weaver B: Spinal muscular atrophy type 1: A noninvasive respiratory management approach. Chest 2000; 117:1100-1105 (Pubitemid 30228371)
6. Schroth MK: Special considerations in the respiratory management of spinal muscular atrophy. Pediatrics 2009; 123:S245-S249
7. Mannaa MM, Kalra M, Wong B, et al: Survival probabilities of patients with childhood spinal muscle atrophy. J Clin Neuromuscul Dis 2009; 10:85-89
8. Oskoui M, Levy G, Garland CJ, et al: The changing natural history of spinal muscular atrophy type 1. Neurology 2007; 69:1931-1936 (Pubitemid 350100351)
9. Norlin C, Osborn LM: Organizational responses to managed care: Issues for academic health centers and implications for pediatric programs. Pediatrics 1998; 101:805-811; discussion 811-812
10. Munsat TL, Davies KE: International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord 1992; 2:423-428 (Pubitemid 23104723)
11. Evans RS, Classen DC, Stevens LE, et al: Using a hospital information system to assess the effects of adverse drug events. Proc Annu Symp Comput Appl Med Care 1993:161-165
12. Harbarth S, Burke J P, Lloyd J F, et al: Clinical and economic outcomes of conventional am-photericin B-associated nephrotoxicity. Clin Infect Dis 2002; 35:e120-e127
13. Ampofo K, Gesteland PH, Bender J, et al: Epidemiology, complications, and cost of hospitalization in children with laboratory-confrmed infuenza infection. Pediatrics 2006; 118:2409-2417 (Pubitemid 46397581)
14. U.S. Census Bureau: 2000 Census of Population and Housing: Summary File 3. Available at: http://factfnder.census.gov. Accessed April 12, 2010
15. Chung BH, Wong VC, Ip P: Spinal muscular atrophy: Survival pattern and functional status. Pediatrics 2004; 114:e548-e553 (Pubitemid 41655751)
16. Bach JR, Baird JS, Plosky D, et al: Spinal muscular atrophy type 1: Management and outcomes. Pediatr Pulmonol 2002; 34:16-22 (Pubitemid 34686706)
17. Swoboda KJ, Prior TW, Scott CB, et al: Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function. Ann Neurol 2005; 57:704-712 (Pubitemid 40628859)
18. Plioplys AV, Kasnicka I, Lewis S, et al: Survival rates among children with severe neurologic disabilities. South Med J 1998; 91:161-172 (Pubitemid 28340297)
19. Bach JR, Saltstein K, Sinquee D, et al: Long-term survival in Werdnig-Hoffmann disease. Am J Phys Med Rehabil 2007; 86:339-345 quiz 346-348, 379 (Pubitemid 46652190)
20. Crawford TO: Concerns about the design of clinical trials for spinal muscular atrophy. Neuromuscul Disord 2004; 14:456-460 (Pubitemid 39141699)
21. Swoboda KJ: Seize the day: Newborn screening for SMA. Am J Med Genet A 2010; 152A:1605-1607
22. Wang CH, Finkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol 2007; 22:1027-1049 (Pubitemid 47308318)